食管癌相关基因研究进展
摘要
食管癌的发生发展是涉及到多种因素多个步骤的病理过程,癌基因的激活和抑癌基因的失活是细胞癌变的分子基础。本文就食管癌相关基因的研究进展进行综述。
出处
《现代肿瘤医学》
CAS
2006年第5期622-624,共3页
Journal of Modern Oncology
参考文献25
-
1Lord RV,O Grady R,Sheehan C,et al.K-ras codon 12 mutations in Barretts oesophagus and adenocarcinomas of the oesophagus and oesophagogasteic junction[J].J Gastroenterol Hepatol,2000,15(7):730 ～706.
-
2Shirasawa S,Furuse M,Yokoyama N,et al.Altered growth of human colon cancer cell lines disrupted at activated Ki -ras[J].Science,2003,260:85.
-
3Sarbia M,Arjumand J,Wolter M,et al.Frequent c-myc amplification in high-grade dyspoasia and adenocarcinoma in Barrett esophagus[J].Am J Clin Pathol,2001,115(6):835 ～840.
-
4Saito H,Tsujitani S,Oka S,et al.The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without P53 protein accumulation[J].Ann Surg Oneol,2002,9(5):450 ～456.
-
5Ikeguchi M,Ueda T,Fukuda K,et al.Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatment[J].Am J Clin Oncol,2002,25(5):454 ～459.
-
6Koyanagi K,Ozawa S,Ando N.Clinical significance of telomrase activity in peripheral blood of patients with esophageal squamous cell carcinoma[J].Ann Thorac Surg,2002,73 (3):927 ～ 932.
-
7Lam KY,Law S,Luk JM,et al.Oesophageal basaloid squamous cell carcinoma:a unique clinicopathological entity with telomerase activity as a prognostic indicator[J].J Pathol,2001,195 (4):435 ～ 442.
-
8Guner D,Sturm I,Hemmati P,et al.Multigene analysis of Rb pathway and apoptosis control in esophageal squamous cell carcinoma identifies patients with good prognosis[J].Int J Cancer,2003,103:445 ～ 454.
-
9Toh Y,Kuwano H,Mori M,et al.Overexpression of metastasisassociated MTA1 m RNA in invasive oesophageal carcinomas[J].Br J Cancer,1999,79(11 ～ 12):1723 ～ 1726.
-
10Kornatsu M,Jepeon S,Arango ME,et al.Potentiation of metastasis by cell surface sialomucin complex (rat MUC4),a multifunctional anti-adhesive glycoprotein[J].Int J Cancer,2000,87(4):480 ～486.
二级参考文献42
-
1Arzimanoglou II et al. Cancer Res,1998.82:1808-1812.
-
2Dietmaier W et al. Cancer Res,1997,57:4749-4753.
-
3Thibodeau SN et al. Cancer Res,1998,58:1713-1719.
-
4Fishel Ret al. Cell,1993,75:1027-1032.
-
5Kolodner RDet al. Genomics,1994,24..516-522.
-
6Fishel Ret al. Science,1994,266:1043-1051.
-
7Peltomaki P,Vasen HFA. Gastroenterology.1997,113 :1146-1151.
-
8Loeb LAet al. Cancer Res,1994,54:5059-5064.
-
9Chung DC, Rustgi AK. Gastroenterology. 1995, 109: 1685-1690.
-
10Rhyu MS. J Natl Cancer Inst,1996,88:240-247.
共引文献19
-
1张功员,刘秋亮,马春晓,乐晓平,葛秀峰,丁一,张钦宪.食管癌组织中hMSH2基因的表达[J].第一军医大学学报,2004,24(6):662-664. 被引量：5
-
2张咏梅,宋光耀,张淑慧,赵晓云,张文杰.MRP1mRNA、GST-πmRNA在食管癌组织中的表达及意义[J].现代肿瘤医学,2005,13(3):332-334. 被引量：2
-
3陈永锋,祝彼得.造血干细胞的研究进展[J].四川解剖学杂志,2005,13(3):26-29. 被引量：8
-
4张功员,马春晓,刘秋亮,乐晓平,丁一,张钦宪.食管癌组织中hMSH2基因启动子区甲基化检测[J].中华肿瘤杂志,2005,27(9):541-543. 被引量：12
-
5李天煜,陈利生.P33ING1与消化道肿瘤的关系[J].广西医科大学学报,2006,23(1):165-167.
-
6陈利生,李天煜,曹云飞,梁君林,张森唐,卫中,唐宗江,高枫.P33ING1在肛管癌中的表达及与P53和细胞凋亡的关系[J].中华胃肠外科杂志,2006,9(4):338-341. 被引量：6
-
7刘飞飞,李梅,王朝晖,吕申.hMSH2蛋白和P53蛋白表达在胃癌发病中的意义[J].大连医科大学学报,2006,28(4):286-287. 被引量：2
-
8梁君林,周永淳,陈利生.p33^(INGI)、p53在结直肠癌中的表达及其相互关系[J].肿瘤,2006,26(10):924-926.
-
9梁君林,周永淳,陈利生.结直肠癌中抑癌基因ING1的表达及其意义[J].结直肠肛门外科,2006,12(5):270-272. 被引量：2
-
10阮永威,金星,侯连泽.乳腺癌系统化疗与微卫星不稳定性的关系[J].中华肿瘤防治杂志,2006,13(23):1790-1792.
-
1常贵生,梁克理,许珂,程爱明,姚潇.食管癌相关基因的研究进展[J].河南肿瘤学杂志,1997,10(4):326-328. 被引量：1
-
2李超霞,吴名耀.食管癌癌基因研究进展[J].汕头大学医学院学报,2003,16(4):248-251. 被引量：3
-
3冯振明.癌基因和抑癌基因对细胞癌变的调控[J].生物学教学,2000,25(8):2-3.
-
4齐连君,陈克林.细胞凋亡与肿瘤[J].医学信息（医学与计算机应用）,2000,13(4):207-208.
-
5孙春晓.肿瘤血管形成的分子基础[J].中国肿瘤临床与康复,1997,4(4):75-77. 被引量：2
-
6王旬果,陈少平,卞侠,郭海生,郭燕春,杨春梅,刘瑞宝,王芳,高鑫.食管癌相关基因及其对放射治疗效果的影响[J].山东医药,2013,53(46):99-101.
-
7刘旭明.肿瘤多药耐药的研究现状[J].四川医学,1998,19(4):325-326.
-
8王瑞年.癌症分子基础与临床(各论) 第十四讲 乳腺和卵巢肿瘤的分子基础与临床[J].中国肿瘤,1998,7(5):25-27.
-
9张梅月,倪凤云,周爱青,李金锋.年轻妇女宫颈癌167例临床分析[J].山东医药,2004,44(2):25-25. 被引量：1
-
10李彪如,王瑞年.癌症分子基础与临床 第七讲 癌症治疗的分子基础(上)[J].中国肿瘤,1997,6(8):25-27. 被引量：1
